Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RXPA 380, a C-terminal specific angiotensin-converting enzyme (ACE) inhibitor, exhibits high affinity with a Ki of 3 nM. It effectively inhibits C-domain mutants of human recombinant ACE, demonstrating potent inhibition with an IC50 of 2.5 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,120.00 | |
50 mg | 8-10 weeks | $ 2,780.00 | |
100 mg | 8-10 weeks | $ 3,700.00 |
Description | RXPA 380, a C-terminal specific angiotensin-converting enzyme (ACE) inhibitor, exhibits high affinity with a Ki of 3 nM. It effectively inhibits C-domain mutants of human recombinant ACE, demonstrating potent inhibition with an IC50 of 2.5 nM. |
Molecular Weight | 617.63 |
Formula | C33H36N3O7P |
CAS No. | 564479-79-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RXPA 380 564479-79-4 RXPA-380 Cbz-PhePsi[PO(2)CH]Pro-Trp-OH. RXPA380 inhibitor inhibit